Palvella Therapeutics (PVLA) FCF Margin Growth (3y) (2017 - 2024)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 10,029.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 723.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -1,409.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 6,066.00 |
| 10 | Palvella Therapeutics | 1.47 Bn | 1.21 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | -198,566.00 |
| Sep 30, 2023 | 16,583.00 |
| Jun 30, 2023 | 2,928.00 |
| Mar 31, 2023 | -44,182.00 |
| Sep 30, 2022 | -332,338.00 |
| Jun 30, 2022 | -22,224.00 |
| Mar 31, 2022 | -3,056.00 |
| Dec 31, 2021 | 136,430.00 |
| Sep 30, 2021 | -33,525.00 |
| Jun 30, 2021 | 124,864.00 |
| Mar 31, 2021 | -83,841.00 |
| Dec 31, 2020 | -71,523.00 |
| Sep 30, 2020 | -111,796.00 |
| Jun 30, 2020 | 29,137.00 |
| Mar 31, 2020 | -203,422.00 |
| Dec 31, 2019 | -24,023.00 |
| Sep 30, 2019 | 39,555.00 |
| Jun 30, 2019 | 35,599.00 |
| Mar 31, 2019 | -33,533.00 |
| Dec 31, 2018 | -227,563.00 |
| Sep 30, 2018 | 72,415.00 |
| Jun 30, 2018 | 186,491.00 |
| Mar 31, 2018 | 241,458.00 |
| Sep 30, 2017 | 96,331.00 |
| Jun 30, 2017 | 10,090.00 |